RxDoctor Payments Data

Marina Isakova, MD

Physical Medicine & Rehabilitation · Brooklyn, NYNPI 1942252556

Payments from drug & device makers

$3,611in general payments, 2019–2025

Across 40 payments — averaging $90.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$1K
  • AbbVie$665
  • SK Life Science, Inc.$311
  • Eisai Inc.$250
  • Argenx US, Inc.$250
  • Scilex Pharmaceuticals Inc.$194
  • plus $928 from 8 others

What the payments were for

  • Food & beverage$3,611100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,611 in reported general payments places this provider in the 85th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York

Medicare billing

Part B allowed, 2024
$222,015
Medicare patients
315
Services billed
5,656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium603$368,568
ZtlidoLidocaine180$60,270
Diclofenac Potassium20$12,753
GraliseGabapentin28$9,180
Lidocaine74$8,073
Gabapentin261$787
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$629
Celecoxib53$329
Pregabalin46$255
Ibuprofen39$166
Tramadol Hcl23$144
Meloxicam104$139
Acetaminophen-CodeineAcetaminophen With Codeine11$95
Naproxen12$51
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$43

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$194$60,270180 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 872 physical medicine & rehabilitation providers in New York.

Other physical medicine & rehabilitation in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →